Silence Therapeutics plc Cash And Cash Equivalents
Silence Therapeutics plc (SLNCF) had Cash And Cash Equivalents of GBP 54.03 million as of 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Assets
ifrs-full:CashAndCashEquivalents · last filed 2024-03-13
- 2023-12-31: Cash And Cash Equivalents 54.03M GBP.
- 2022-12-31: Cash And Cash Equivalents 54.82M GBP.
- 2021-12-31: Cash And Cash Equivalents 73.54M GBP.
- 2020-12-31: Cash And Cash Equivalents 27.45M GBP.
GBP
| Period end | Cash And Cash Equivalents |
|---|---|
| 2023-12-31 | 54.03M GBP 20-F · filed 2024-03-13 |
| 2022-12-31 | 54.82M GBP 20-F · filed 2024-03-13 |
| 2021-12-31 | 73.54M GBP 20-F · filed 2024-03-13 |
| 2020-12-31 | 27.45M GBP 20-F · filed 2024-03-13 |
| 2019-12-31 | 13.52M GBP 20-F · filed 2023-03-15 |
| 2018-12-31 | 21.49M GBP 20-F · filed 2022-03-17 |
| 2017-12-31 | 42.74M GBP 20-F/A · filed 2021-04-29 |
USD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2023-12-31 | $68.80M 20-F · filed 2024-03-13 |